162 related articles for article (PubMed ID: 12083402)
1. SNP market view: opportunities, technologies, and products.
Wypgant M
Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
[No Abstract] [Full Text] [Related]
2. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
3. R&D deals boom in 2004.
Lawrence S
Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
[No Abstract] [Full Text] [Related]
4. BeadArray-based solutions for enabling the promise of pharmacogenomics.
Fan JB; Hu SX; Craumer WC; Barker DL
Biotechniques; 2005 Oct; 39(4):583-8. PubMed ID: 16235573
[TBL] [Abstract][Full Text] [Related]
5. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
6. Biotech drugs come of age; policymakers take notice.
Iglehart JK
Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
[No Abstract] [Full Text] [Related]
7. Applying technologies towards safe and effective medicines.
Roses AD
Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
[No Abstract] [Full Text] [Related]
8. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
9. Screening for drug discovery: the leading question.
Smith A
Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
[No Abstract] [Full Text] [Related]
10. Pharmacogenetics initiative galvanizes public and private sectors.
Smaglik P
Nature; 2001 Mar; 410(6826):393-4. PubMed ID: 11268220
[No Abstract] [Full Text] [Related]
11. Novel technology and the development of pharmacogenetics within the pharmaceutical industry.
Gibson N; Jawaid A; March R
Pharmacogenomics; 2005 Jun; 6(4):339-56. PubMed ID: 16004553
[TBL] [Abstract][Full Text] [Related]
12. Helicos BioSciences.
Milos P
Pharmacogenomics; 2008 Apr; 9(4):477-80. PubMed ID: 18384261
[TBL] [Abstract][Full Text] [Related]
13. The life science revolution.
Enriquez J
Manag Care; 2002 Sep; 11(9 Suppl):15-8. PubMed ID: 12369338
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics--pivotal to the future of the biopharmaceutical industry.
Foot E; Kleyn D; Palmer Foster E
Drug Discov Today; 2010 May; 15(9-10):325-7. PubMed ID: 20298799
[No Abstract] [Full Text] [Related]
15. [Pharmacogenomics: way to individual therapy].
Piruzian AL
Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215
[TBL] [Abstract][Full Text] [Related]
16. Differentiating genomics companies.
James R
Nat Biotechnol; 2000 Feb; 18(2):153-5. PubMed ID: 10657119
[TBL] [Abstract][Full Text] [Related]
17. The biotech drug market.
Lawrence S
Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
[No Abstract] [Full Text] [Related]
18. Genome-based pharmacogenetics and the pharmaceutical industry.
Roses AD
Nat Rev Drug Discov; 2002 Jul; 1(7):541-9. PubMed ID: 12120260
[TBL] [Abstract][Full Text] [Related]
19. Biotech drug market steadily expands.
Lawrence S
Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
[No Abstract] [Full Text] [Related]
20. Clinical applications of whole-genome association studies: future applications at the bedside.
Motsinger AA; Ritchie MD; Dobrin SE
Expert Rev Mol Diagn; 2006 Jul; 6(4):551-65. PubMed ID: 16824029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
